Hoppenot Herve
SEC CIK 1596492 · EDGAR
BoughtSold
Most active insiders at BCYC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Kevin | CEO, Dir | — | $258.0K |
| 2 | Skynner Michael | CTO | — | $79.1K |
| 3 | Milnes Alistair | COO | — | $62.0K |
| 4 | Hannay Michael Charles Ferguson | CHIEF PROD, SUPPLY CHAIN OFF | — | $56.8K |
| 5 | Young Alethia | CFO | — | $54.6K |
| 6 | Thompson Travis Alvin | CFO | — | $27.3K |
| 7 | Perry Jennifer Scott | COO | — | $13.0K |
| 8 | Swanton Robert Charles | Dir | — | $872.10 |
| 9 | Sands Stephen H. | Dir | — | — |
| 10 | Riva Alessandro | Dir | — | — |
| 15 | Hoppenot Herve | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Hoppenot Herve | Dir | A - Grant | $0.00 | +3,032 | 15.5K | +24% | $0 |
| 2025-12-10 | 2025-12-08 | INCY | Incyte | Hoppenot Herve | Dir | F - Tax | $96.70 | -2,843 | 326.8K | -0.9% | -$274.9K | |
| 2025-11-12 | 2025-11-10 | INCY | Incyte | Hoppenot Herve | Dir | S - Sale | $105.46 | -187.5K | 329.6K | -36% | -$19.77M | |
| D | 2025-09-10 | 2025-09-08 | BCYC | BICYCLE THERAPEUTICS PLC | Hoppenot Herve | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
| M | 2025-07-16 | 2025-07-14+ | INCY | Incyte | Hoppenot Herve | Special Advisor to the CEO, Dir | F - Tax | $69.14 | -9,674 | 517.1K | -2% | -$668.8K |
| 2025-07-07 | 2025-07-02 | INCY | Incyte | Hoppenot Herve | Special Advisor to the CEO, Dir | F - Tax | $68.17 | -42.8K | 526.8K | -8% | -$2.92M | |
| D | 2025-06-30 | 2025-06-26 | INCY | Incyte | Hoppenot Herve | Special Advisor to the CEO, Dir | A - Grant | $0.00 | +6,016 | 569.6K | +1% | $0 |
| 2025-04-03 | 2025-04-01 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +66.9K | 563.6K | +13% | $0 | |
| D | 2024-07-17 | 2024-07-15 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | F - Tax | $64.25 | -4,961 | 496.7K | -1.0% | -$318.7K |
| D | 2024-07-17 | 2024-07-15 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +41.0K | 501.6K | +9% | $0 |
| 2024-07-03 | 2024-07-02 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | F - Tax | $59.02 | -41.7K | 460.6K | -8% | -$2.46M | |
| 2024-02-16 | 2024-02-14 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +41.6K | 502.3K | +9% | $0 | |
| D | 2023-07-18 | 2023-07-14 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +43.2K | 434.9K | +11% | $0 |
| 2023-07-06 | 2023-07-03 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | F - Tax | $62.08 | -43.5K | 391.7K | -10% | -$2.70M | |
| D | 2023-01-24 | 2023-01-20 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +29.2K | 435.1K | +7% | $0 |
| D | 2022-07-06 | 2022-07-02 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +60.4K | 427.1K | +16% | $0 |
| D | 2022-07-06 | 2022-07-05 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | F - Tax | $79.25 | -21.2K | 405.9K | -5% | -$1.68M |
| M | 2021-11-23 | 2021-11-19 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +15.5K | 345.4K | +5% | $0 |
| D | 2021-07-07 | 2021-07-02 | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +44.3K | 347.5K | +15% | $0 |
| DM | 2021-07-07 | 2021-07-02+ | INCY | Incyte | Hoppenot Herve | COB, CEO, Dir, Pres | F - Tax | $83.56 | -17.7K | 331.4K | -5% | -$1.47M |
Purchase Sale Sale after option exercise All abbreviations